Document Classification

Section Type: RESULTS

Text: On evaluation of changes from baseline to 24 months among 255 patients randomized to implant and systemic therapy (479 eyes with uveitis), the implant and systemic therapy groups had an improvement in visual acuity of +6. 0 and +3. 2 letters (P = 0. 16, 95 % confidence interval on difference in improvement between groups, -1. 2 to +6. 7 letters, positive values favoring implant), an improvement in vision-related quality of life of +11. 4 and +6. 8 units (P = 0. 043), a change in EuroQol-EQ5D health utility of +0. 02 and -0. 02 (P = 0. 060), and residual active uveitis in 12 % and 29 % (P = 0. 001), respectively.